ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Letter to the Editor



Ga-68 PSMA PET/CT: Enhancing diagnostic precision and clinical decision-making in prostate cancer

Fatih Bati.



Abstract
 Download PDF Post

Gallium-68 labeled prostate-specific membrane antigen (Ga-68 PSMA) positron emission tomography-computed tomography scan (PET/CT) imaging has profoundly transformed prostate cancer diagnosis and management in nuclear medicine practice in recent years. This letter briefly addresses its diagnostic superiority, therapeutic impact, adherence to current guidelines, and practical insights into its application in Türkiye.
Firstly, Ga-68 PSMA PET/CT has demonstrated considerable diagnostic superiority compared to conventional imaging modalities such as CT, magnetic resonance imaging (MRI), and bone scintigraphy. The prospective multicenter ProPSMA trial illustrated significantly higher accuracy for Ga-68 PSMA PET/CT (92%) compared to conventional imaging (65%) in identifying metastatic prostate cancer, representing a clinically significant improvement (27% absolute difference, p

Key words: Ga-68 PSMA PET/CT, prostate cancer, theranostics, diagnostic accuracy

Bibliomed Article Statistics

12
10
17
13
R
E
A
D
S

15

10

15

10
D
O
W
N
L
O
A
D
S
09101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.